Strategic Partners A/S: directors' dealings · Denmark · Finanstilsynet DK DK:strategic-partners-as-36e036 DK0060910917 DK DK · Finanstilsynet DK Mcap 26M€ Healthcare
Explore the full insider trade history of Strategic Partners A/S, a listed issuer based in Denmark. Shares are listed on DK DK, under the authority of Finanstilsynet DK. Operating in the Healthcare sector, Strategic Partners A/S has published 10 insider filings. Market capitalisation: €25.6m. The latest transaction was reported on 1 February 2021 (Other). Among the most active insiders: Unknown. Every trade is accessible without an account.
Financial data FY ended December 2025 · cache
Income statement
Revenue 309 k€
Net income −859 k€ -278.0% margin
Balance sheet & cash
Market cap 25.6 M€
Total debt 40.0 M€
Free Cash Flow −2.1 M€
Profitability & ownership
ROE -4.6%
ROA -7.1%
% insiders 56.7%
% institutions 5.9%
Last declaration on 1 February 2021
Declarations 10 total
Executives ● Other7 DK FSA
€2,361 17,561 shares @ €0.1344 0.0092% mcap 3.6% of flow DK0060910917⌘
Share Outside a trading venueDK:1002512 · 1 Feb 2021
Executives ● Purchase26 DK FSA
U
Unknown Chief Financial Officer of Orphazyme A/S €3,718 400 shares @ €9.2962 0.015% mcap 5.6% of flow DK0060910917⌘
Share Nasdaq Copenhagen A/S – XCSEDK:957260 · 2 Oct 2020
Ideal exit: 29 Jun 2021 (T+270) Executives ● Other13 DK FSA
€15,839 1,927 shares @ €8.2196 0.062% mcap 23.9% of flow DK0060910917⌘
Share Outside a trading venueDK:953904 · 1 Sept 2020
Executives ● Purchase6 DK FSA
€840 6,250 shares @ €0.1344 0.0033% mcap 1.3% of flow DK0060910917⌘
Share Outside a trading venueDK:949883 · 29 Jul 2020
Ideal exit: 25 Apr 2021 (T+270) Executives ● Purchase27 DK FSA
U
Unknown Chief Financial Officer of Orphazyme A/S €6,372 500 shares @ €12.7449 0.025% mcap 9.6% of flow DK0060910917⌘
Share Nasdaq Copenhagen A/S – XCSEDK:948847 · 16 Jul 2020
Ideal exit: 12 Apr 2021 (T+270) Executives ● Purchase6 DK FSA
€175 14 shares @ €12.475 0.0007% mcap 0.3% of flow DK0060910917⌘
Share Nasdaq Copenhagen A/S – XCSEDK:948665 · 15 Jul 2020
Ideal exit: 11 Apr 2021 (T+270) Executives ● Other17 DK FSA
€28,336 3,451 shares @ €8.211 0.11% mcap 42.8% of flow DK0060910917⌘
Share Outside a trading venueDK:947560 · 3 Jul 2020
Executives ● Purchase6 DK FSA
€102 10 shares @ €10.2222 0.0004% mcap 0.2% of flow DK0060910917⌘
Share Nasdaq Copenhagen A/S - XCSEDK:917303 · 7 Jan 2020
Ideal exit: 3 Oct 2020 (T+270) Executives ● Grant6 DK FSA
03,451 shares 0DK0060910917⌘
Share
DK:898188 · 29 Jul 2019
Executives ● Purchase11 DK FSA
€8,530 1,011 shares @ €8.437 0.033% mcap 12.9% of flow DK0060910917⌘
Share Nasdaq Copenhagen A/S - XCSEDK:898076 · 26 Jul 2019
Ideal exit: 21 Apr 2020 (T+270)